3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
30
Lymphoma, Follicular
9
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma
7
Lymphoma, Non-Hodgkin
5
Leukemia, Lymphocytic, Chronic, B-Cell
4
Neoplasms
3
Smoldering Multiple Myeloma
2
Myelodysplastic Syndromes
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Burkitt Lymphoma
2
Recurrence
1
Neoplasms, Plasma Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
GATA2 Deficiency
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
pembrolizumab
18
Specimen Handling
17
Magnetic Resonance Spectroscopy
12
Biopsy
12
Paclitaxel
9
Carboplatin
8
Radiosurgery
7
Nivolumab
7
trastuzumab deruxtecan
6
Pemetrexed
6
Leucovorin
6
Irinotecan
6
Fulvestrant
6
Fluorouracil
6
Bevacizumab
6
palbociclib
5
Oxaliplatin
5
Letrozole
5
Gemcitabine
5
Cetuximab
5
Taxes
4
Cisplatin
4
Capecitabine
4
olaparib
3
enzalutamide
3
durvalumab
3
Ipilimumab
3
Docetaxel
3
130-nm albumin-bound paclitaxel
3
sacituzumab govitecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Lenalidomide
×
30 days
×
Clear all
No trials found.